跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Approved
STANDARD
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Mylan Medical S.A.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 15, 2021
Approval ID
3717849d762f3f92
Company
Mylan Medical S.A.S.
Type
Standard
Approval Details
Approval Id
3717849d762f3f92
Drug Cima Aemps Name
DYMISTA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Register Number
3400927563119IP1
Holder Company Name
Mylan Medical S.A.S.
Marketing Company Name
Ecofar Productos S.L.
Authorization Date
2021-12-15
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
1 mg/g - 0,365 mg/g
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Mylan Medical S.A.S.
Active Ingredients
AZELASTINA HIDROCLORURO
0,1 g
FLUTICASONA PROPIONATO
0,0365 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 15, 2021
Approval ID
3717849d762f3f92
Type
Standard
Back to CIMA-AEMPS Approvals